PepGen Inc.
PEPGNasdaqCIK 1835597HealthcareFiscal year ends Dec 31
Reports and events: 99 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-03-2908:15 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0000950170-24-038417 |
| 2024-03-1516:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-069110 |
| 2024-03-1307:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-030505 |
| 2024-03-1119:56 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-033131 |
| 2024-03-0616:23 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-027178 |
| 2024-03-0616:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-027111 |
| 2024-03-0407:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-024350 |
| 2024-02-2008:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-016804 |
| 2024-02-1316:16 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-019896 |
| 2024-02-0707:36 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-025921 |
| 2024-01-1708:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-004824 |
| 2024-01-0807:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-002679 |
| 2023-12-1808:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-070944 |
| 2023-11-1508:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-064008 |
| 2023-11-0808:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-060702 |
| 2023-11-0808:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-060693 |
| 2023-10-1207:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-052999 |
| 2023-09-0616:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-046722 |
| 2023-09-0608:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-046572 |
| 2023-08-0808:27 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-205630 |
| 2023-08-0808:17 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-039392 |
| 2023-08-0808:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039391 |
| 2023-06-2216:05 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-029394 |
| 2023-06-1316:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-027696 |
| 2023-05-3016:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-024842 |
| 2023-05-1807:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-022875 |
| 2023-05-1107:11 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-020829 |
| 2023-05-1107:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-020826 |
| 2023-04-2816:00 ET | DEF 14A | Proxy statementPeriod 2023-06-22 | 0000950170-23-015751 |
| 2023-03-2716:54 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-010040 |
| 2023-03-2316:16 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-009500 |
| 2023-03-2316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-009480 |
| 2023-03-2208:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-009049 |
| 2022-12-0708:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-026120 |
| 2022-11-1409:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-024767 |
| 2022-11-1008:16 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-024186 |
| 2022-11-1008:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-024184 |
| 2022-09-2806:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-018928 |
| 2022-09-2208:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-22-018744 |
| 2022-08-1208:16 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-017013 |
| 2022-08-1208:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-017010 |
| 2022-07-2208:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-22-012897 |
| 2022-06-2316:49 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-22-073935 |
| 2022-06-1608:34 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-011719 |
| 2022-06-1608:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-011718 |
| 2022-05-2016:30 ET | SC 13D | Ownership report, active investor | 0001104659-22-063397 |
| 2022-05-0417:08 ET | S-1/A | Registration statement, amended | 0001193125-22-140581 |
| 2022-05-0206:24 ET | S-1/A | Registration statement, amended | 0001193125-22-135245 |
| 2022-04-1516:55 ET | S-1 | Registration statement | 0001193125-22-106884 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.